415 related articles for article (PubMed ID: 33865978)
1. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors.
Reddy S; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 Aug; 26(8):1944-1952. PubMed ID: 33865978
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
3. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
4. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
5. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery.
Zhan C; Lu W
Curr Pharm Biotechnol; 2012 Sep; 13(12):2380-7. PubMed ID: 23016643
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme.
Ortega-Berlanga B; Gonzalez C; Navarro-Tovar G
Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):8. PubMed ID: 33772646
[TBL] [Abstract][Full Text] [Related]
7. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
[TBL] [Abstract][Full Text] [Related]
9. LDL receptors and their role in targeted therapy for glioma: a review.
Pawar S; Koneru T; McCord E; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 May; 26(5):1212-1225. PubMed ID: 33609780
[TBL] [Abstract][Full Text] [Related]
10. Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.
Zhou W; Chen C; Shi Y; Wu Q; Gimple RC; Fang X; Huang Z; Zhai K; Ke SQ; Ping YF; Feng H; Rich JN; Yu JS; Bao S; Bian XW
Cell Stem Cell; 2017 Nov; 21(5):591-603.e4. PubMed ID: 29100012
[TBL] [Abstract][Full Text] [Related]
11. Novel Nano-Drug Delivery System for Brain Tumor Treatment.
Qiu Z; Yu Z; Xu T; Wang L; Meng N; Jin H; Xu B
Cells; 2022 Nov; 11(23):. PubMed ID: 36497021
[TBL] [Abstract][Full Text] [Related]
12. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
13. Natural polymeric nanocarriers in malignant glioma drug delivery and targeting.
Gao Y; Wang R; Zhao L; Liu A
J Drug Target; 2021 Nov; 29(9):960-973. PubMed ID: 33745392
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
15. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
[TBL] [Abstract][Full Text] [Related]
16. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review.
Li J; Zhao J; Tan T; Liu M; Zeng Z; Zeng Y; Zhang L; Fu C; Chen D; Xie T
Int J Nanomedicine; 2020; 15():2563-2582. PubMed ID: 32368041
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
Lim SH; Yee GT; Khang D
Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in drug delivery systems for targeting brain tumors.
Zhao Y; Yue P; Peng Y; Sun Y; Chen X; Zhao Z; Han B
Drug Deliv; 2023 Dec; 30(1):1-18. PubMed ID: 36597214
[TBL] [Abstract][Full Text] [Related]
20. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
Wang Z; Sun H; Yakisich JS
Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
